Inhibition of ceramide de novo synthesis mitigates atherosclerosis

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Miss Suet Yen Chong

NUS Yong Loo Lin School of Medicine, Singapore (Singapore)

5 More presentations in this session

Presentation thumbnail

Zibotentan in microvascular angina: a randomized, placebo-controlled, crossover trial

Doctor A. Morrow (Glasgow, GB)

Abstract Slides Video

Presentation thumbnail

Experimental evidence on colchicine's mode of action in human carotid artery plaques

Mrs I. Steenbuck (Freiburg, DE)

Abstract Slides Video

Presentation thumbnail

The short-term prognosis of salvianolate use during hospitalization in patients with acute myocardial infarction

Doctor R. Guo (Tianjin, CN)

Abstract Slides Video

Presentation thumbnail

Safety, tolerability, and basic pharmacokinetic parameters of AUX-001, a once-daily extended release nicorandil in healthy volunteers under fasting and fed conditions

Doctor U. Tigoer (Saratoga Springs, US)

Abstract Slides Video

Presentation thumbnail

SHR-1918, a monoclonal antibody against angiopoietin-like 3, in healthy subjects: a randomized, double-blind, placebo-controlled, phase 1 study

Mr C. Lv (Shanghai, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Novel drugs for cardiovascular diseases

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

State-of-the-art lecture on pharmacotherapy for acute coronary syndromes

Congress Presentation

State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention

Congress Presentation

Medical treatment works! Contemporary implementation into clinical practice

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources